| Robert William Lauvetz, MD | |
|
816 S Pine St, Stillwater, OK 74074-4349 | |
| (405) 377-3858 | |
| (405) 624-2771 |
| Full Name | Robert William Lauvetz |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 37 Years |
| Location | 816 S Pine St, Stillwater, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851353890 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 20088 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stillwater Medical Center | Stillwater, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stillwater Medical Center Authority | 2365353794 | 143 |
News Archive
Paladin Labs Inc. and Somaxon Pharmaceuticals, Inc. today announced that Paladin has filed a New Drug Submission (NDS) that has been accepted for review by Health Canada for Silenor (doxepin) for the treatment and symptomatic relief of insomnia.
Religion and spirituality have distinct but complementary influences on health, new research from Oregon State University indicates.
Veterans of Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) frequently experience high rates of PTSD along with symptoms of depression and pain. However, little is known about why these symptoms occur together or the most effective treatments that can be used to alleviate them. One approach that may yield new insights is to search for biomarkers - indicators of a biological state that can be easily and reliably measured in people with an illness - to see if their presence or absence can predict symptoms that an individual will experience and identify optimal treatment strategies.
Researchers at National Jewish Health have discovered a signaling pathway that is crucial to the devastating effects of acute lung injury. The data, obtained from cells, animals and ALI patients, suggest several potential therapeutic targets. Experimental blockade of one of the targets significantly reduced flooding of the lungs that is the hallmark of ALI.
New research accepted by the Journal of Molecular Recognition confirms that a revolutionary technology developed at Wake Forest University will slash years off the time it takes to develop drugs - bringing vital new treatments to patients much more quickly.
› Verified 9 days ago
| Entity Name | Stillwater Medical Center Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558377135 PECOS PAC ID: 2365353794 Enrollment ID: O20040525001304 |
News Archive
Paladin Labs Inc. and Somaxon Pharmaceuticals, Inc. today announced that Paladin has filed a New Drug Submission (NDS) that has been accepted for review by Health Canada for Silenor (doxepin) for the treatment and symptomatic relief of insomnia.
Religion and spirituality have distinct but complementary influences on health, new research from Oregon State University indicates.
Veterans of Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) frequently experience high rates of PTSD along with symptoms of depression and pain. However, little is known about why these symptoms occur together or the most effective treatments that can be used to alleviate them. One approach that may yield new insights is to search for biomarkers - indicators of a biological state that can be easily and reliably measured in people with an illness - to see if their presence or absence can predict symptoms that an individual will experience and identify optimal treatment strategies.
Researchers at National Jewish Health have discovered a signaling pathway that is crucial to the devastating effects of acute lung injury. The data, obtained from cells, animals and ALI patients, suggest several potential therapeutic targets. Experimental blockade of one of the targets significantly reduced flooding of the lungs that is the hallmark of ALI.
New research accepted by the Journal of Molecular Recognition confirms that a revolutionary technology developed at Wake Forest University will slash years off the time it takes to develop drugs - bringing vital new treatments to patients much more quickly.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert William Lauvetz, MD 816 S Pine St, Stillwater, OK 74074-4349 Ph: (405) 377-3858 | Robert William Lauvetz, MD 816 S Pine St, Stillwater, OK 74074-4349 Ph: (405) 377-3858 |
News Archive
Paladin Labs Inc. and Somaxon Pharmaceuticals, Inc. today announced that Paladin has filed a New Drug Submission (NDS) that has been accepted for review by Health Canada for Silenor (doxepin) for the treatment and symptomatic relief of insomnia.
Religion and spirituality have distinct but complementary influences on health, new research from Oregon State University indicates.
Veterans of Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) frequently experience high rates of PTSD along with symptoms of depression and pain. However, little is known about why these symptoms occur together or the most effective treatments that can be used to alleviate them. One approach that may yield new insights is to search for biomarkers - indicators of a biological state that can be easily and reliably measured in people with an illness - to see if their presence or absence can predict symptoms that an individual will experience and identify optimal treatment strategies.
Researchers at National Jewish Health have discovered a signaling pathway that is crucial to the devastating effects of acute lung injury. The data, obtained from cells, animals and ALI patients, suggest several potential therapeutic targets. Experimental blockade of one of the targets significantly reduced flooding of the lungs that is the hallmark of ALI.
New research accepted by the Journal of Molecular Recognition confirms that a revolutionary technology developed at Wake Forest University will slash years off the time it takes to develop drugs - bringing vital new treatments to patients much more quickly.
› Verified 9 days ago
Dr. Randall J Willis, M.D. Urology Medicare: Medicare Enrolled Practice Location: 801 S Walnut St, Stillwater, OK 74074 Phone: 405-743-3760 | |
Dr. Nathan Rademaker, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1201 S Adams St, Stillwater, OK 74074 Phone: 405-742-5300 |